Porphyrinic compounds for use in flow cytometry

1. In a method of detecting a target compound, cell or particle by flow cytometry, wherein said target is labeled with a detectable luminescent compound, the improvement comprising utilizing as said detectable luminescent compound a compound comprising a porphyrinic macrocycle;

wherein said detectable luminescent compound is excited by light at an excitation wavelength band and detected by emitted light at an emission wavelength band;

and wherein said emission wavelength band has a full width at half maximum peak of not more than 30 nanometers:

and wherein said porphyrinic macrocycle is:

a bacteriochlorin of Formula AI:

wherein:

M is a metal or is absent;

X is selected from the group consisting of Se, NH, CH 2 , O and S;

R 1 , R 2 , R 3 , R 4 R 5 , R 6 R 7 and R 8 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, protein, peptide, antibody, and polyalkylene oxide;

subject to the proviso that neither R 1 nor R 2 is H; or neither R 3 nor R 4 is H;

or R 1 and R 2 together are ═O;

or R 3 and R 4 together form spiroalkyl,

or R 3 and R 4 together are ═O;

or a bacteriophorbine of Formula DIc or DIc′:

wherein:

M is a metal or is absent;

X i , X 2 , X 3 and X 4 are each independently selected from the group consisting of Se, NH, CH 2 , O and S;

R 1 , R 2 , R 3 , R 4 ,R 5 ,R 6 ,R 7 ,R 8 ,R 11 ,R 12 ,R 13 ,R 14 ,R 15 ,R 16 ,R 21 ,R 22 ,R 31 , and R 32 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, acyl, formyl, carboxylic acid, acylamino, ester, amide, hydroxyl, nitro, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acyloxy, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, protein, peptide, antibody, and polyalkylene oxide;

wherein each pair of R 1 and R 2 , R 11 and R 12 , R 21 and R 22 , or R 31 and R 32 , can together form ═O;

wherein each of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , or R 13 and R 14 , can together form spiroalkyl;

wherein R 2 and R 3 can together form a double bond; and wherein R 12 and R 13 can together form a double bond;

or a salt thereof.

2. The method of claim 1 , wherein:

said excitation wavelength band has a peak between 350 and 900 nanometers; and

said emission wavelength band has a peak between 550 and 1000 nanometers.

3. The method of claim 1 , wherein:

said porphyrinic macrocycle is a bacteriochlorin;

said excitation wavelength band has a peak between 350 and 450 nanometers; and

said emission wavelength band has a peak between 700 and 1000 nanometers.

4. The method of claim 1 , wherein said detectable luminescent compound is excited by light at an excitation wavelength band and detected by emitted light at an emission wavelength band;

wherein said excitation wavelength band and said emission wavelength band each have peaks that are separated from one another by from 10 to 100 nanometers;

and wherein said emission wavelength band has a full width at half maximum peak of not more than 25 nanometers.

5. In a method of detecting and distinguishing first and second target compounds, cells or particles by flow cytometry, wherein said first target is labelled with a first detectable compound and said second target is labeled with a second detectable compound, the improvement comprising:

utilizing a compound comprising a first porphyrinic macrocycle as said first detectable compound and a compound comprising a second porphyrinic macrocycle as said second detectable compound;

wherein each of said first and second detectable compounds are excited at an excitation wavelength band;

and wherein:

(i) each of said first and second detectable compounds have a different emission wavelength band, said different emission wavelength bands characterized by peaks that are separated from one another by at least 5 nanometers; or

(ii) said second compound has a lifetime at least 20 percent greater than said first compound;

and wherein said first and second porphyrinic macrocycles are each independently: a bacteriochlorin of Formula AI:

wherein:

M is a metal or is absent;

X is selected from the group consisting of Se, NH, CH 2 , O and S;

R 1 , R 2 , R 3 , R 4 R 5 , R 6 R 7 and R 8 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, protein, peptide, antibody, and polyalkylene oxide;

subject to the proviso that neither R 1 nor R 2 is H; or neither R 3 nor R 4 is H;

or R 1 and R 2 together are ═O;

or R 3 and R 4 together form spiroalkyl, or R 3 and R 4 together are ═O;

or a bacteriophorbine of Formula DIc or DIc′:

wherein:

M is a metal or is absent;

X 1 , X 2 , X 3 and X 4 are each independently selected from the group consisting of Se, NH, CH 2 , O and S;

R 1 ,R 2 ,R 3 ,R 4 ,R 5 ,R 6 , R 7 ,R 8 ,R 11 , R 12 ,R 13 ,R 14 ,R 15 ,R 16 ,R 21 ,R 22 ,R 31 and R 32 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, acyl, formyl, carboxylic acid, acylamino, ester, amide, hydroxyl, nitro, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acyloxy, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, protein, peptide, antibody, and polyalkylene oxide;

wherein each pair of R 1 and R 2 , R 11 and R 12 , R 21 and R 22 , or R 31 and R 32 , can together form ═O;

wherein each of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , or R 13 and R 14 , can together form spiroalkyl;

wherein R 2 and R 3 can together form a double bond; and wherein R 12 and R 13 can together form a double bond;

or a salt thereof.

6. The method of claim 5 , wherein

both of said excitation wavelength bands have a peak between 350 and 900 nanometers; and

both of said emission wavelength bands have a peak between 550 and 1000 nanometers.

7. The method of claim 5 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by at least 50 nanometers.

8. The method of claim 5 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by 10 to 50 nanometers;

and wherein each of said different emission wavelength bands have a full width at half maximum peak of not more than 30 nanometers.